Full Text View
Tabular View
Study Results
Related Studies
ALK21-013: Efficacy and Safety of Medisorb® Naltrexone (VIVITROL®) in Adults With Opioid Dependence
This study has been completed.
Study NCT00678418   Information provided by Alkermes

First Received on May 14, 2008.   Last Updated on January 11, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Opiate Dependence
Additional conditions recognized in this trial
Opioid-Related Disorders
More general conditions related to this trial
Mental Disorders
Substance-Related Disorders
Interventions listed in this trial
VIVITROL® 380 mg
Placebo
Additional drug interventions recognized in this trial
Analgesics, Opioid
Naltrexone
More general drug interventions related to this trial
Analgesics
Central Nervous System Agents
Central Nervous System Depressants
Narcotic Antagonists
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
Alkermes


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services